Related Experiment Videos
Initial experience with dexmedetomidine in paediatric-aged patients
Joseph D Tobias1, John W Berkenbosch
1Department of Child Health, The University of Missouri, Columbia, Missouri 65212, USA. tobiasj@health.missouri.edu
Paediatric Anaesthesia
|March 8, 2002
Summary
This study explores the preliminary use of dexmedetomidine, an alpha2 adrenergic agonist, in pediatric patients for sedation and controlled hypotension. Findings suggest potential applications in pediatric anesthesia and critical care settings.
Area of Science:
- Pediatric Anesthesiology
- Critical Care Medicine
- Pharmacology
Background:
- Dexmedetomidine is an alpha2 adrenergic agonist with sedative and analgesic properties.
- Its use in pediatric populations is less established than in adults.
- Understanding its application in children is crucial for advancing pediatric care.
Purpose of the Study:
- To present preliminary clinical experience with dexmedetomidine in children.
- To evaluate its efficacy and safety in various pediatric scenarios.
- To discuss its potential role in pediatric anesthesia and critical care.
Main Methods:
- Dexmedetomidine administration in three distinct clinical scenarios: sedation during mechanical ventilation, intraoperative controlled hypotension, and procedural sedation.
- Review of preliminary clinical data from pediatric patients.
- Discussion of physiological effects and adult data.
Main Results:
- Preliminary data on dexmedetomidine use in pediatric patients across different clinical settings.
- Demonstrated feasibility of administration for sedation and hypotension.
- Insights into physiological responses in children.
Conclusions:
- Dexmedetomidine shows promise as a therapeutic option in pediatric anesthesia and critical care.
- Further research is warranted to fully establish its role and optimize its use in children.
- Preliminary experience suggests a potential for safe and effective application.